Jose Leon, MD
Rheumatology · Auburn, ALNPI 1437388907
Payments from drug & device makers
Across 743 payments — averaging $22.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$2K
- UCB, Inc.$2K
- Johnson & Johnson$1K
- Novartis$1K
- GSK$1K
- plus $6K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 130 | $2,617 |
| Amgen(2 entities) | 109 | $2,128 |
| UCB, Inc. | 79 | $1,538 |
| Johnson & Johnson(2 entities) | 53 | $1,371 |
| Novartis | 53 | $1,256 |
| GSK | 54 | $1,231 |
| Pfizer | 60 | $1,223 |
| AstraZeneca(2 entities) | 44 | $1,197 |
| Mallinckrodt Hospital Products Inc. | 27 | $921 |
| ANI Pharmaceuticals, Inc. | 18 | $552 |
| Lilly USA, LLC | 26 | $464 |
| Aurinia Pharma U.S., Inc. | 17 | $435 |
| Radius Health, Inc. | 16 | $402 |
| E.r. Squibb & Sons, L.L.C. | 19 | $338 |
| Sobi, Inc | 9 | $173 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Kyowa Kirin, Inc. | 3 | $66 |
| Scilex Pharmaceuticals Inc. | 3 | $64 |
| Sanofi | 2 | $54 |
| Genentech USA, Inc. | 3 | $53 |
| Boehringer Ingelheim | 2 | $53 |
| Hikma Pharmaceuticals USA | 3 | $44 |
| Fresenius Kabi USA, LLC | 2 | $41 |
| Ferring Pharmaceuticals Inc. | 1 | $40 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $25 |
| Mallinckrodt Enterprises LLC | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $20 |
| Organon | 1 | $19 |
| Bioventus LLC | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
| Antares Pharma, Inc. | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
How this compares
$16,540 in reported general payments places this provider in the 65th percentile of 90 rheumatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Auburn
- Christopher AdamsAuburn$21K
- Zarmeena AliAuburn$8K
- Adahli MasseyAuburn$5K
- Jeffrey CurtisBirmingham$17.6M
- Kenneth SaagBirmingham$8.2M
- Vishala ChindaloreAnniston$3.5M
- Anthony TurkiewiczMountain Brk$2.5M
- Harry SchroederBirmingham$938K
- Jose Rubio MosqueraBirmingham$823K
- David McLainBirmingham$588K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.